iRhythm Holdings (IRTC) Capital Expenditures (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.41% |
| Dec 31, 2025 | -20.96% |
| Sep 30, 2025 | -24.55% |
| Jun 30, 2025 | 14,790.91% |
| Mar 31, 2025 | -98.07% |
| Dec 31, 2024 | -74.52% |
| Sep 30, 2024 | 381.52% |
| Jun 30, 2024 | -197.62% |
| Mar 31, 2024 | -75.76% |
| Dec 31, 2023 | 224,183.33% |
| Sep 30, 2023 | 99.78% |
| Jun 30, 2023 | -198.73% |
| Mar 31, 2023 | 137.31% |
| Dec 31, 2022 | -456.50% |
| Sep 30, 2022 | -60.86% |
| Jun 30, 2022 | 7,090.67% |
| Mar 31, 2022 | -95.14% |
| Dec 31, 2021 | -65.25% |
| Sep 30, 2021 | 124.68% |
| Jun 30, 2021 | 40.66% |
| Mar 31, 2021 | 78.13% |
| Dec 31, 2020 | -57.79% |
| Sep 30, 2020 | 156.81% |
| Jun 30, 2020 | -35.95% |
| Mar 31, 2020 | -71.19% |
| Dec 31, 2019 | 251.38% |
| Sep 30, 2019 | -5.85% |
| Jun 30, 2019 | 109.50% |
| Mar 31, 2019 | 14.20% |
| Dec 31, 2018 | 2.19% |
| Sep 30, 2018 | 30.68% |
| Jun 30, 2018 | 0.90% |
| Mar 31, 2018 | 21.62% |
| Dec 31, 2017 | 71.56% |
| Sep 30, 2017 | -43.87% |
| Jun 30, 2017 | -19.42% |
| Mar 31, 2017 | 24.63% |
| Dec 31, 2016 | 25.27% |
| Sep 30, 2016 | 83.41% |
| Jun 30, 2016 | -37.78% |
| Mar 31, 2016 | 149.62% |